Faculty profile

Brian Leber

Back to faculty

Professor EmeritusMedicineMcMaster University

Brian Leber

Professor Emeritus

Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2025

Email ORCID

Supervision signals

Emeritus professors are retired and rarely take new students.
No graduate courses on record.
82 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.

These signals come from public records; CIHR grant records currently run to 2022. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

390

Publications

16,301

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar iDORCID OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

leberb@mcmaster.ca (905) 525-9140 ext. 76384

Research

Research areas, by share of publications

Acute Myeloid Leukemia ResearchMedicine
Chronic Lymphocytic Leukemia ResearchMedicine
Cell death mechanisms and regulationBiochemistry, Genetics and Molecular Biology

Research areas are derived from OpenAlex topics of their publications.

From the 150 most recent of 390 publications.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Murphy T, Zhang B, Zhang T, King I, Capo-Chichi J-M, Gupta V, Maze D, McNamara CJ, Minden MD, Schimmer AD

Haematologica20266 citations

DOI: 10.3324/haematol.2025.287777

Controversies in the Management of AML in Older Patients: A Canadian Perspective

Schuh AC, Brandwein J, Elsawy M, Sanford D, Leber B

Current Oncology20261 citationsSenior author

DOI: 10.3390/curroncol33070431

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey

Modi D, Houston BL, Leber B, Jamula E, Heddle N, Hillis C, Zeller MP, Berg T, Arnold DM

Transfusion20261 citations

DOI: 10.1111/trf.70202

Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia

Salter B, Ge S, Garcia-Horton A, Berg T, Leber B, Walker I, Dalmia S, Radford M, Lepic K, Khalaf D

Leukemia and Lymphoma20261 citations

DOI: 10.1080/10428194.2025.2577861

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study

Salter B, Garcia-Horton A, Walker I, Leber B, Lepic K, Mian H, Gayowsky A, Pond GR, Seow H, Berg T

Blood Cancer Journal2026

DOI: 10.1038/s41408-026-01454-6

A comparison of overall survival and quality of life in MDS patients treated with Azacytidine vs Decitabine

England JT, Zhang L, Yee K, Geddes M, Zhu N, Shamy A, Leitch H, Sabloff M, Christou G, Houston BL

Blood Neoplasia2026

DOI: 10.1016/j.bneo.2026.100293

Chimerism practices across Canadian transplant centres: review of current standards and variations

Gravina M, Lepic K, Leber B, Walker I, Berg T, Lam W, Garcia-Horton A, Dalmia S, Grafodatskaya D, Butcher DT

Frontiers in Transplantation2026

DOI: 10.3389/frtra.2026.1879340

Abstract 3403: High content imaging of patient cells to identify CLL and AML patient cohorts that predict drug responses

Andrews DW, Li MX, Buzina A, Brito GC, Usta S, Leber B, Tsui H, Spaner D

Cancer Research2026

DOI: 10.1158/1538-7445.am2026-3403

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus

Schuh AC, Chornenki N, Elemary MA, Elsawy M, Houston BL, Leber B, Mozessohn L, Sabloff M, Salter B, Sanford D

Current Oncology2026

DOI: 10.3390/curroncol33070429

Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS

Radford M, Garcia-Horton A, Badami R, Jin E, Usmani N, Grafodatskaya D, McCready E, Khalaf D, Walker I, Leber B

Transplantation and Cellular Therapy202517 citationsSenior author

DOI: 10.1016/j.jtct.2024.11.006

Researchers with similar interests

Tobias Berg

Oncology

Acute Myeloid Leukemia Research

Alejandro Garcia Horton

Oncology

Acute Myeloid Leukemia Research

Christopher Hillis

Oncology

Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research

Shreyash Dalmia

Oncology

Acute Myeloid Leukemia Research

Kylie Lepic

Oncology

Acute Myeloid Leukemia Research

Tom Kouroukis

Oncology

Chronic Lymphocytic Leukemia Research

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Acute Myeloid Leukemia Research Dear Professor Leber, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Brian Leber

Research

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Controversies in the Management of AML in Older Patients: A Canadian Perspective

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey

Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia

Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study

A comparison of overall survival and quality of life in MDS patients treated with Azacytidine vs Decitabine

Chimerism practices across Canadian transplant centres: review of current standards and variations

Abstract 3403: High content imaging of patient cells to identify CLL and AML patient cohorts that predict drug responses

Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus

Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS

Frequent collaborators

Irwin Ronald Walker

Tobias Berg

Ronan Foley

Kylie Lepic

Cecile Fradin

Christopher Hillis

Researchers with similar interests

Tobias Berg

Alejandro Garcia Horton

Christopher Hillis

Shreyash Dalmia

Kylie Lepic

Tom Kouroukis